Cornerstone Planning Group
JAZZ icon

Cornerstone Planning Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cornerstone Planning Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-11
Closed -$2.76K – 949
2026
Q2 		$2.76K Hold
11
– – ﹤0.01% 1236
2026
Q1 		$2.34K Hold
11
– – ﹤0.01% 1266
2025
Q4 		$1.82K Hold
11
– – ﹤0.01% 1211
2025
Q3 		$1.5K Hold
11
– – ﹤0.01% 1218
2025
Q2 		$1.24K Hold
11
– – ﹤0.01% 1060
2025
Q1 		$1.15K Buy
11
+4
+57% +$522 ﹤0.01% 1102
2024
Q4 		$871 Buy
+7
New +$825 ﹤0.01% 986
2023
Q3 		– Sell
-11
Closed -$1.36K – 1259
2023
Q2 		$1.36K Buy
+11
New +$1.48K ﹤0.01% 1281
2022
Q4 		$1.25K Buy
+8
New +$1.17K ﹤0.01% 1309

Other funds holding JAZZ

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
Argent Capital Management
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Perpetual Ltd
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

Cornerstone Planning Group's JAZZ Position: Q3 2026 in Review

Cornerstone Planning Group sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 11 shares — an estimated $2.76K sold.

Cornerstone Planning Group first reported a position in JAZZ in Q4 2022 and held it in 9 quarters. The position peaked at $2.76K in Q2 2026. 134 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Cornerstone Planning Group reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 11 Jazz Pharmaceuticals shares in Q3 2026, an estimated $2.76K.
  • Cornerstone Planning Group first reported a position in Jazz Pharmaceuticals in Q4 2022 and held it in 9 quarters.
  • Cornerstone Planning Group's Jazz Pharmaceuticals position peaked at $2.76K in Q2 2026.
  • 134 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.